St. Jude Medical, Inc.  

(Public, NYSE:STJ)   Watch this stock  
Find more results for STJ
65.87
-0.47 (-0.71%)
Jan 30 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 65.45 - 66.79
52 week 54.80 - 71.90
Open 65.70
Vol / Avg. 3.77M/2.23M
Mkt cap 18.90B
P/E 19.08
Div/yield 0.27/1.64
EPS 3.45
Shares 287.00M
Beta 1.33
Inst. own 85%
Apr 14, 2015
Q1 2015 St. Jude Medical Inc Earnings Release (Estimated) - 9:30AM EDT - Add to calendar
Jan 28, 2015
Q4 2014 St. Jude Medical Inc Earnings Release
Jan 28, 2015
Q4 2014 St. Jude Medical Inc Earnings Call
Jan 14, 2015
St. Jude Medical Inc at JPMorgan Healthcare Conference
Jan 14, 2015
Preliminary Q4 2014 St. Jude Medical Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q1 (Jan '15) 2015
Net profit margin 16.54% 16.99%
Operating margin 19.46% 20.47%
EBITD margin - 28.94%
Return on average assets 8.67% 9.34%
Return on average equity 21.89% 23.65%
Employees 16,000 -
CDP Score - -

Address

ONE ST JUDE MEDICAL DRIVE
ST. PAUL, MN 55117
United States - Map
+1-651-7562000 (Phone)
+1-651-7563301 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

St. Jude Medical, Inc. (St. Jude) develops, manufactures and distributes cardiovascular medical devices. Its principal products in each therapy area are: Cardiac Rhythm Management - tachycardia implantable cardioverter defibrillator systems (ICDs) and bradycardia pacemaker systems (pacemakers); Cardiovascular - vascular products, which include vascular closure products, pressure measurement guidewires, optical coherence tomography (OCT) imaging products, vascular plugs and other vascular accessories, and structural heart products, which include heart valve replacement and repair products and structural heart defect devices; Atrial Fibrillation - electrophysiology (EP) introducers and catheters, advanced cardiac mapping, navigation and recording systems and ablation systems, and Neuromodulation - neurostimulation products. In August 2014, the Company acquired privately held NeuroTherm, Inc., a manufacturer of interventional pain management therapies.

Officers and directors

Daniel J. Starks Chairman of the Board, President, Chief Executive Officer
Age: 59
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Donald J. Zurbay Chief Financial Officer, Vice President - Finance
Age: 46
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Joel D. Becker President - Americas Division
Age: 46
Bio & Compensation  - Reuters
Eric S. Fain M.D. Group President - St. Jude Medical
Age: 53
Bio & Compensation  - Reuters
Denis M. Gestin President - International
Age: 50
Bio & Compensation  - Reuters
Michael T. Rousseau Chief Operating Officer
Age: 58
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
John C. Heinmiller Executive Vice President
Age: 59
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Mark W. Murphy Vice President - Information Technology, Chief Information Officer
Age: 45
Bio & Compensation  - Reuters
Lisa Malden Andrade Chief Marketing Officer, Vice President
Age: 42
Bio & Compensation  - Reuters
Scott P. Thome Vice President - Global Operations and Supply Chain
Age: 51
Bio & Compensation  - Reuters